期刊文献+

姜黄素联合美沙拉嗪治疗溃疡性结肠炎小鼠的疗效 被引量:6

Therapeutic Effect of Curcumin Combined with Mesalazine on Ulcerative Colitis in Mice
原文传递
导出
摘要 目的探讨姜黄素联合美沙拉嗪治疗溃疡性结肠炎小鼠的疗效及作用机制。方法 50只小鼠分成5组:正常组、模型组、姜黄素联合美沙拉嗪治疗组、姜黄素治疗组和美沙拉嗪治疗组,采用传统的葡聚糖酸钠法制备小鼠溃疡性结肠炎模型。自造模成功次日,姜黄素联合美沙拉嗪治疗组予姜黄素灌肠及美沙拉嗪灌胃治疗;姜黄素治疗组仅予姜黄素灌肠治疗;美沙拉嗪治疗组予美沙拉嗪灌胃治疗;正常组及模型组均予9 g.L-1盐水灌胃。以上均为每日1次,共10 d。给药10 d后,观察其结肠病理组织学变化,并采用流式细胞术检测其结肠上皮细胞凋亡率,采用ELISA法测定小鼠血清IL-2、IL-10水平。结果姜黄素联合美沙拉嗪治疗组结肠指数、结肠损伤评分、病理组织学评分及细胞凋亡率较模型组均明显下降(Pa<0.01)。与姜黄素治疗组和美沙拉嗪治疗组比较,姜黄素联合美沙拉嗪治疗组结肠损伤评分、病理组织学评分及细胞凋亡率有所下降,且差异均有统计学意义(Pa<0.05);与模型组比较,姜黄素联合美沙拉嗪治疗组、姜黄素治疗组和美沙拉嗪治疗组血清IL-10水平均显著下降,血清IL-2水平显著升高(Pa<0.01)。与姜黄素治疗组和美沙拉嗪治疗组比较,姜黄素联合美沙拉嗪治疗组血清IL-10水平显著下降,血清IL-2水平显著升高(Pa<0.05)。结论姜黄素联合美沙拉嗪治疗小鼠溃疡性结肠炎,效果较单用美沙拉嗪好,姜黄素联合美沙拉嗪治疗小鼠溃疡性结肠炎在降低IL-10、升高IL-2水平方面较单用美沙拉嗪显著。 Objective To investigate the effect of curcumin combined with mesalazine on the treatment of ulcerative colitis in mice and its mechanism.Methods Fifty mice were divided into 5 groups:normal group,model group,curcumin combined with mesalazine treatment group,curcumin treatment group and mesalazine treatment group.The mouse models with ulcerative colitis were copied by dextran sulfate so-dium traditional method.Since the model was successfully constructed,the next day,curcumin combined received mesalazine treatment group received curcumin enema treatment and mesalazine orally fed of each;curcumin treatment group received curcumin enema treatment;mesalazine treatment group received mesalazine orally fed;normal group and model group were treated with correspondingly 9 g·L-1 saline.All once every day,a total for 10 d.Ten days after administration,the pathological changes were observed,and flow cytometry was used to detect the apo-ptosis of colonic epithelial cells,ELISA was used to detect the serum IL-2 and IL-10 levels.Results The colonic damage scores,histolo-gical scores and the apoptosis rate in curcumin combined with mesalazine treatment group were significantly lower than those in model group(Pa0.01).Compared with the curcumin treatment group and mesalazine treatment group,the injury score,histological score and the apoptosis rate in curcumin combined with mesalazin treatment group decreased,and the differences were statistically significant(Pa0.05).Compared with model group,IL-10 levels decreased and IL-2 levels increased significantly in curcumin combined with mesalazine treatment group and the curcumin treatment group and mesalazine treatment group(Pa0.01).Compared with the curcurnin treatment group and mesalazine treatment group,IL-10 levels decreased and IL-2 levels increased significantly in curcumin combined with mesalazine treatment group(Pa0.05).Conclusion Curcumin combined with mesalazine therapy is better than using mesalazine alone on mice with ulcerative colitis,and also effective in decreasing IL-10 level and increasing IL-2 level compared with using mesalazine alone.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2011年第7期532-534,共3页 Journal of Applied Clinical Pediatrics
关键词 溃疡性结肠炎 姜黄素 美沙拉嗪 实验研究 小鼠 ulcerative colitis curcumin mesalazine experimental study mouse
  • 相关文献

参考文献12

  • 1张志军,刘懿,王磊,蒋晓芸,陈坚,孙旭,钟良,孙大裕.TLR4mAb对急性期溃疡性结肠炎小鼠结肠黏膜中促炎因子TNF-α、IFN-γ、IL-1β的影响[J].复旦学报(医学版),2008,35(2):176-180. 被引量:22
  • 2Liu DY, Zhao HM, Zhao N, et al. Pharmacological effects of ba - weixi-lei powder on ulcerative colitis in rats with enema application[J]. Am J Chin Med,2006,34(3 ) :461-469.
  • 3石忠峰,陈蔚文,李茹柳,李秋霞.白术黄芪汤及其有效部位组方对小鼠溃疡性结肠炎的疗效观察[J].中药新药与临床药理,2007,18(2):87-90. 被引量:30
  • 4Fan H, Shen L,Tang Q,et al. Effect of Wumeiwan on cytokines TNF - α, IL-6,IL- 8 ,IL- 10 and expression of NF- κBp65 in rats with ulcerative colitis[J]. J Huanzhong Univ Sci Technolog Med Sci,2009,29(5), 650 - 654.
  • 5Beltrán C J, Candia E, Erranz B, et al. Peripheral cytokine profile in children patients with Crohn's disease and ulcerative colitis [J]. Eur Cytokine Netw ,2009,20 ( 1 ) :33 - 38.
  • 6Ebert EC, Panja A, Das KM. Patients with inflammatory bowel disease may have a transforming growth factor - β - ,interleukin (IL) -2 - or IL - 10 - deficient state induced by intrinsic neutralizing antibodies[ J]. Clin Exp Immunol,2009,155 ( 1 ) : 65 - 71.
  • 7Barmeyer C, Harren M, Schmitz H, et al. Mechanisms of dian'hea in the interleukin - 2 - deficient mouse model of colonic inflammation[J]. Am J Physiol Gastrointest Liver Physio1,2004,286 ( 2 ) :244 - 252.
  • 8Louis E, Libioulle C, Reenaers C,et al. Genetics of ulcerative colitis:The come - back of interleukin 10 [ J ]. Gut, 2009,58 (9) : 1173 - 1176.
  • 9王晓娣.炎症性肠病患者肠黏膜组织细胞凋亡[J].世界华人消化杂志,2008,16(28):3197-3199. 被引量:3
  • 10Kruis W, Kiudelis G, Racz 1, et al. Once daily versus three times daily mesalazine granules in active ulcerative colitis:A doube -blind, double - dummy, randomised, non - inferiority trial [ J ]. Gut, 2009,58 (2) :233 - 240.

二级参考文献21

  • 1Bing Xia,Yu-Hong Yu,Qiu-Sha Guo,Xiang-Yin Li,Li Jiang,Jin Li.Association of Fas-670 gene polymorphism with inflammatory bowel disease in Chinese patients[J].World Journal of Gastroenterology,2005,11(3):415-417. 被引量:15
  • 2Suzhen Zhang,Xuhui Zhao,Dechun Zhang.Cellular and Molecular Immunopathogenesis of Ulcerative Colitis[J].Cellular & Molecular Immunology,2006,3(1):35-40. 被引量:25
  • 3Silvio Danese,Claudio Fiocchi.Etiopathogenesis of inflammatory bowel diseases[J].World Journal of Gastroenterology,2006,12(30):4807-4812. 被引量:65
  • 4郑里,王淑仙,崔德玉,崔艳英.介绍一种简便的炎症性肠疾病的评价方法[J].中国药理学通报,1996,12(5):468-469. 被引量:29
  • 5Murthy S,Cooper HS,Yoshitake H,et al.Combination therapy of pentoxifylline and TNF-α monoclonal antibody in dextran sulphate-induced mouse colitis[J].Aliment Pharmacol Ther,1999,13(2):251-260.
  • 6Cooper HS,Murthy SN,Shah RS,et al.Clinic opathologic study of dextran sulfate sodium experimental murine colitis[J].Lab Invest,1993,69(2):238-249.
  • 7Isabel V,Catalina A.A new flavonoid derivative,dosmalfate,attenuates the development of dextran sulphate sodium-induced colitis in mice[J].International Immunopharmacology,2003,(3):1731-1741.
  • 8Hove TT,Coxbaz A,Amitai H,et al.Blockade of endogeneous IL-18 ameliorates TNBS-induced colitis by decereasing local TNF-α production in mice[J].Gastroenterol,2001,121(6):1372-1379.
  • 9Elson CO,Beagiey KW,Sharmanov AT,et al.Hapten-induced model of murine inflammatory bowel disease:mucosal immune responses and protection by tolerance[J].J Immunol,1996,157(5):2174.
  • 10Kxawisz JE,Sharon P,Stenson WF.Quantitative assay fox acute intestinal inflammation based on myelopexoxidase[J].Gastroenterology,1984,87:1344-1350.

共引文献50

同被引文献69

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部